Detalles de la búsqueda
1.
A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II.
Aliment Pharmacol Ther
; 55(7): 856-866, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34935160
2.
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study.
Dig Liver Dis
; 50(12): 1299-1304, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30077465
Resultados
1 -
2
de 2
1
Próxima >
>>